Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Nevro Corp.

Nevro Corp. develops and offers solutions for chronic pain management through its HFX therapy technology, which includes FDA-approved devices and AI-based recommendations for pain relief.

Metric
Company Name	Nevro Corp.
Symbol	NVRO
MSH ID	COM:NEVRO
Market	STOCKS
Sector	Healthcare
Industry	Medical - Devices
Country	US
Stage
Employee Count	1.22K
Website	nevro.com
LinkedIn
Founders

Metric
Market Cap	294.20M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	425.17M
Revenue (LTM)
Revenue (NTM)
Gross Profit	278.52M
EBITDA	-87.77M
Operating Income	-99.31M
Net Income	-92.21M
EPS	-2.56
Diluted EPS	-2.56
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.68
Operating Profit Margin	-0.22
EBITDA Margin	-0.21
Net Profit Margin	-0.18
Return on Equity	-0.27
Return on Assets	-0.13
Return on Capital Employed	-0.18

COM:NEVRO

Nevro Corp.

Last Close

4.36

22/11 21:00

Market Cap

294.20M

Beta: -

Volume Today

544.52K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-5.82
P/B Ratio	2.09
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.17
EV Multiple	-0.05

Metric
Days Sales Outstanding	59.55
Days Payables Outstanding	75.76
Days Inventory Outstanding	322.27
Operating Cycle	387.44
Cash Conversion Cycle	330.86
Asset Turnover	0.72

Metric
Operating Cash Flow	-64.66M
Free Cash Flow	-73.25M
Cash Flow to Debt	-0.28
Operating Cash Flow/Sales	-0.15
Free Cash Flow Yield	-0.12

Metric
Cash & Equivalents	104.22M
Accounts Receivable	-211K
Inventory	118.68M
Goodwill	38.16M
Debt to Capitalization	0.44
Debt to Assets	0.35
Current Ratio	6.55
Quick Ratio	5.57

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.14
R&D to Revenue	0.13
SG&A to Revenue